Christopher Evans

Based in the Firm’s New York office, Chris Evans is a Partner in Simpson Thacher’s Fund Transactions Practice. Chris focuses on a broad range of GP-level transactions involving prominent alternative asset managers. Previously a Managing Director on the GP Stakes team at Blackstone, Chris counsels asset managers on cutting-edge minority stake investments, control sale, joint ventures and other transactions. He also advises private fund sponsors on the organization and management of private investment funds across asset classes, succession planning and strategic initiatives.

Prior to joining Simpson Thacher, Chris was a Managing Director on the GP Stakes team at Blackstone, where he worked on sponsor minority stakes deals and advised Blackstone’s portfolio GPs on business strategy. Previously, he covered alternative asset managers in the investment banks at J.P. Morgan and Lazard. Earlier in his career, Chris was a Senior Policy Advisor at the U.S. Treasury Department. He also spent several years in private practice, including at Simpson Thacher.

While at Blackstone, Chris advised the firm’s portfolio GPs, such as Francisco Partners, New Mountain Capital and Rockpoint, on the structuring and launch strategy of numerous investment vehicles across private equity, credit, real estate and real assets. Those structures spanned commingled funds, funds-of-one and separately managed accounts.

Chris serves as the Board President for the New York Metropolitan Chapter of the Juvenile Diabetes Research Foundation.

Chris received his J.D., magna cum laude, in 2002 from Duke University School of Law where he was editor of Duke Law Journal. He received his B.A., summa cum laude, in 1998 in History and Government. He is admitted to practice in New York.